<table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="tbl2" position="float"><object-id pub-id-type="doi">10.7554/eLife.03821.009</object-id><label>Table 2.</label><caption><p>Cox regression models for variables associated with clinical progression in untreated individuals followed up from PHI</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.03821.009">http://dx.doi.org/10.7554/eLife.03821.009</ext-link></p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="3">Univariable unadjusted</th><th colspan="2">Multivariable adjusted</th></tr><tr><th>Covariate</th><th>HR (95% CI)</th><th>p Value</th><th>HR (95% CI)</th><th>p Value</th></tr></thead><tbody><tr><td>Total DNA (log<sub>10</sub> DNA copies)</td><td>4.16 (2.1&#8211;8.26)</td><td>&lt;0.001</td><td>3.57 (1.58&#8211;8.08)</td><td>0.002</td></tr><tr><td>Viral load (log<sub>10</sub> RNA copies)</td><td>1.74 (1.14&#8211;2.67)</td><td>0.011</td><td>1.25 (0.80&#8211;1.95)</td><td>0.33</td></tr><tr><td>CD4+ T cell count/100 cells</td><td>0.66 (0.53&#8211;0.82)</td><td>&lt;0.001</td><td>0.67 (0.53&#8211;0.84)</td><td>&lt;0.001</td></tr></tbody></table><table-wrap-foot><fn><p>Univariable and multivariable cox regression models were used to determine predictors of clinical progression in untreated individuals followed up from Primary HIV-1 Infection. Progression was determined according to reaching the SPARTAC trial primary endpoint (<xref ref-type="bibr" rid="bib7">Chun et al., 2010</xref>). Co-variables analysed were baseline (i.e. first pre-therapy trial sample) Total HIV-1 DNA, baseline plasma viral load and baseline CD4+ T cell count.</p></fn></table-wrap-foot></table-wrap>